FDA WILL NOT REQUIRE CLINICAL TRIAL DATA TO AUTHORIZE REDESIGNED COVID BOOSTERS OR ANY MEDICATIONS

Date: December 15, 2022Author: ᎢᎠᎺBᎡᎠr ᏍᏔrCᎯld 0 Comments

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: